KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Repligen (RGEN) Shares Outstanding (Diluted Average) (2016 - 2022)

Repligen (RGEN) has disclosed Shares Outstanding (Diluted Average) for 10 consecutive years, with $57455.0 as the latest value for Q4 2022.

  • On a quarterly basis, Shares Outstanding (Diluted Average) changed 0.33% to $57455.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $57455.0, a 0.33% change, with the full-year FY2022 number at $57455.0, changed 0.33% from a year prior.
  • Shares Outstanding (Diluted Average) was $57455.0 for Q4 2022 at Repligen, roughly flat from $57264.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $56.9 million in Q1 2021 to a low of $44327.0 in Q1 2018.
  • A 5-year average of $32.2 million and a median of $47.7 million in 2019 define the central range for Shares Outstanding (Diluted Average).
  • Peak YoY movement for Shares Outstanding (Diluted Average): surged 114694.38% in 2019, then plummeted 99.89% in 2020.
  • Repligen's Shares Outstanding (Diluted Average) stood at $45.5 million in 2018, then grew by 8.21% to $49.2 million in 2019, then tumbled by 99.89% to $53892.0 in 2020, then grew by 6.26% to $57264.0 in 2021, then increased by 0.33% to $57455.0 in 2022.
  • Per Business Quant, the three most recent readings for RGEN's Shares Outstanding (Diluted Average) are $57455.0 (Q4 2022), $57264.0 (Q4 2021), and $56.8 million (Q2 2021).